"How SmithKline Beecham Makes Better Resource Allocation Decisions"

Publications

“How SmithKline Beecham Makes Better Resource Allocation Decisions”

by Paul Sharpe and Tom Keelin

In this paper, former SDG consultant Tom Keelin and Paul Sharpe of then-SmithKline Beecham detail the portfolio management process SDG developed to maximize the value of SmithKline Beecham’s drug research & development portfolio. This work required a transformation in SmithKline Beecham’s analytic and organizational processes and has been an HBR best-seller since its publication.

Published in 1998 in the Harvard Business Review. The article is available at this link.

Client Testimonial

“In the end, we estimated that our portfolio was worth $2.6 billion more than it was when we started. This was powerful confirmation that our efforts were worthwhile.”

—Vice President and Director
Pharmaceutical Company

Publications

“How SmithKline Beecham Makes Better Resource Allocation Decisions”

Client Testimonial

Cookies